Evidence map›Paper›PMID 35675811›Full record

ArticleCell reports2022

Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles.

Aniuska Becerra-Artiles, J Mauricio Calvo-Calle, Mary Dawn Co, Padma P Nanaware, John Cruz, Grant C Weaver, Liying Lu, Catherine Forconi, Robert W Finberg, Ann M Moormann and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Functional SARS-CoV-2 cross-reactive CD4Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Aniuska Becerra-ArtilesDepartment of Pathology, UMass Chan Medical School, Worcester, MA 01655, USA.
J Mauricio Calvo-CalleDepartment of Pathology, UMass Chan Medical School, Worcester, MA 01655, USA.
Mary Dawn CoDepartment of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.
Padma P NanawareDepartment of Pathology, UMass Chan Medical School, Worcester, MA 01655, USA.
John CruzDepartment of Pathology, UMass Chan Medical School, Worcester, MA 01655, USA.
Grant C WeaverDepartment of Pathology, UMass Chan Medical School, Worcester, MA 01655, USA.
Liying LuDepartment of Pathology, UMass Chan Medical School, Worcester, MA 01655, USA.
Catherine ForconiDepartment of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.
Robert W FinbergDepartment of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.
Ann M MoormannDepartment of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.
Lawrence J SternDepartment of Pathology, UMass Chan Medical School, Worcester, MA 01655, USA; Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester, MA 01655, USA. Electronic address: lawrence.stern@umassmed.edu.
University of Massachusetts Chan Medical School · USUMass Memorial Health Care · US

Funding

cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
HLA-DO / H2-O: modulation of MHC-II peptide diversity and Treg population controlR01AI127869 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 2018 to 2022
$2.7M
NHLBI NIH HHS 75N92020D00005NIAID NIH HHS 75N93022D00005NIAID NIH HHS 75N93023D00005NIAID NIH HHS R01 AI127869NIAID NIH HHS T32 AI007349NIDA NIH HHS 75N95020D00005ORFDO NIH HHS 75N99020D00005
6 · The paper itself

Abstract

Sequence homology between SARS-CoV-2 and common-cold human coronaviruses (HCoVs) raises the possibility that memory responses to prior HCoV infection can affect T cell response in COVID-19. We studied T cell responses to SARS-CoV-2 and HCoVs in convalescent COVID-19 donors and identified a highly conserved SARS-CoV-2 sequence, S

Indexed as

COVID-19SARS-CoV-2AllelesCD4-Positive T-LymphocytesCOVID-19 VaccinesEpitopes, T-LymphocyteHLA AntigensHumansmRNA VaccinesReceptors, Antigen, T-CellCOVID-19 VaccinesEpitopes, T-LymphocyteHLA AntigensmRNA VaccinesReceptors, Antigen, T-CellCD4 T cellsCP: ImmunologyCP: Microbiologyheterologous immunitymajor histocompatibility complexseasonal coronavirusspike fusion peptide proximal regionT cell receptor repertoire

Identifiers

PMID35675811
PMCPMC9135679
OpenAlexW4282030676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.